Comprehensive miRNA analysis of conjunctival epithelium of Stevens-Johnson syndrome patients in the chronic stage

Comprehensive miRNA analysis of conjunctival epithelium of Stevens-Johnson syndrome patients in the chronic stage

Bibliographic Details
Main Authors:	MAYUMI Ueta, Hiromi Nishigaki, Chie Sotozono, Norihiko Yokoi, Shigeru Kinoshita
Format:	Article
Language:	English
Published:	Elsevier 2020-08-01
Series:	World Allergy Organization Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S1939455120301605

Similar Items

Prostaglandin E receptor subtype EP3 expression in human conjunctival epithelium and its changes in various ocular surface disorders.
by: Mayumi Ueta, et al.
Published: (2011-01-01)

Japan: Diagnosis and Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
by: Chie Sotozono, et al.
Published: (2021-07-01)

Challenges in the management of bilateral eyelid closure in Stevens-Johnson Syndrome
by: Yulia Aziza, et al.
Published: (2022-06-01)

Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
by: Kosuke Saito, et al.
Published: (2016-01-01)

HLA-A*0206 with TLR3 polymorphisms exerts more than additive effects in Stevens-Johnson syndrome with severe ocular surface complications.
by: Mayumi Ueta, et al.
Published: (2012-01-01)

Difference in the plasma level of miR‐628‐3p in atopic dermatitis patients with/without atopic keratoconjunctivitis
by: Mayumi Ueta, et al.
Published: (2021-12-01)

Mapping of susceptible variants for cold medicine-related Stevens–Johnson syndrome by whole-genome resequencing
by: Yosuke Kawai, et al.
Published: (2021-02-01)

Categorization of the Ocular Microbiome in Japanese Stevens–Johnson Syndrome Patients With Severe Ocular Complications
by: Mayumi Ueta, et al.
Published: (2021-11-01)

Positive regulation of innate immune response by miRNA-let-7a-5p
by: Mayumi Ueta, et al.
Published: (2023-01-01)

Usefulness of a New Therapy Using Rebamipide Eyedrops in Patients with VKC/AKC Refractory to Conventional Anti-Allergic Treatments
by: Mayumi Ueta, et al.
Published: (2014-01-01)

Multi-state model for predicting ocular progression in acute Stevens-Johnson syndrome/toxic epidermal necrolysis.
by: Fumie Kinoshita, et al.
Published: (2021-01-01)

Marsupialization of conjunctival inclusion cyst in Stevens-Johnson syndrome
by: Jinglan Li, et al.
Published: (2023-02-01)

Evaluation of conjunctival bacterial flora in patients with Stevens-Johnson Syndrome
by: Luciana Frizon, et al.
Published: (2014-03-01)

Respiratory complications of Stevens-Johnson syndrome (SJS): 3 cases of SJS-induced obstructive bronchiolitis
by: Yoshiko Kaneko, et al.
Published: (2020-07-01)

Evaluation of patients with erythema exudativum multiforme, Stevens‐Johnson syndrome, and toxic epidermal necrolysis treated at our department during the previous 9‐year period
by: Midori Kawasaki‐Nagano, et al.
Published: (2022-10-01)

Differences in gene regulation by TLR3 and IPS-1 signaling in murine corneal epithelial cells
by: Seitaro Komai, et al.
Published: (2023-05-01)

Association of IKZF1 SNPs in cold medicine-related Stevens–Johnson syndrome in Thailand
by: Patchima Chantaren, et al.
Published: (2019-11-01)

Drugs causing severe ocular surface involvements in Japanese patients with Stevens–Johnson syndrome/toxic epidermal necrolysis
by: Nahoko Kaniwa, et al.
Published: (2015-10-01)

Bilateral conjunctival retention cysts in the aftermath of <i>Stevens-Johnson syndrome</i>
by: Singh Gurdeep, et al.
Published: (2008-01-01)

Human leukocyte antigen B*0702 is protective against ocular Stevens–Johnson syndrome/toxic epidermal necrolysis in the UK population
by: Gibran F. Butt, et al.
Published: (2021-02-01)

Effectiveness of Single-Dose Oral Pilocarpine Administration in Patients with Sjögren’s Syndrome
by: Aoi Komuro, et al.
Published: (2023-12-01)

STEVENS JOHNSON SYNDROME
by: Julia Fitriany, et al.
Published: (2019-07-01)

Stevens-Johnson syndrom
by: I Ja Sultanov, et al.
Published: (2010-03-01)

Steven-Johnson Syndrome
by: Pauline Joy F. Santos, et al.
Published: (2017-07-01)

Management of Large Conjunctival Cysts in a Patient with Stevens-Johnson Syndrome: A Case Report and Review of the Literature
by: Sadid Hooshmandi, et al.
Published: (2023-10-01)

Matrix metalloproteinase 9 is associated with conjunctival microbiota culture positivity in Korean patients with chronic Stevens-Johnson syndrome
by: Jayoon Moon, et al.
Published: (2022-04-01)

Stevens-Johnson Syndrome : An Update
by: Dhar Sandipan, et al.
Published: (1997-01-01)

The Relationship between Subjective Symptoms and Quality of Life in Conjunctivochalasis Patients
by: Aoi Komuro, et al.
Published: (2021-01-01)

LRIG1 as a potential novel marker for neoplastic transformation in ocular surface squamous neoplasia.
by: Maho Nagata, et al.
Published: (2014-01-01)

Stevens-Johnson syndrome is an immune catastrophe
by: E.K. Isaeva
Published: (2019-06-01)

Drugs Induced Stevens-Johnson Syndrome
by: Elif ÖNDER, et al.
Published: (2010-05-01)

Cataract surgery in Steven Johnson syndrome
by: Srinivasan Renuka, et al.
Published: (2007-01-01)

Cefotaxime-induced Stevens-Johnson syndrome
by: Sandeep Lahiry
Published: (2016-10-01)

Multidisciplinary care in Stevens-Johnson syndrome
by: Swapna S. Shanbhag, et al.
Published: (2020-04-01)

The Ocular Microbiome in Stevens-Johnson Syndrome
by: Thanachaporn Kittipibul, et al.
Published: (2021-05-01)

Phenytoin Induced Stevens-Johnson Syndrome
by: Kumar Pramod, et al.
Published: (1996-01-01)

Ciprofloxacin Induced Stevens-Johnson Syndrome
by: Ramachandra R Annapureddy, et al.
Published: (2018-01-01)

Pearls in the management of Stevens–Johnson syndrome
by: Geetha Iyer, et al.
Published: (2019-01-01)

Suçiçeği ile ilişkili Stevens-Johnson sendromu
by: Hasibe Artaç, et al.
Published: (2013-01-01)

Stevens-Johnson syndrome. Presentation of a patient
by: Dianelí Lorely Reyes Hernández, et al.
Published: (2015-12-01)